References
- Ahmed B, Ali Ashfaq U, Usman Mirza M. 2018. Medicinal plant phytochemicals and their inhibitory activities against pancreatic lipase: Molecular docking combined with molecular dynamics simulation approach. Nat Prod Res. 32(10):1123–1129.
- Egloff M P, Marguet F, Buono G, Verger R, Cambillau C, van Tilbeurgh H. 1995. The 2.46. ANG. Resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry. 34(9):2751–2762.
- Heck AM, Yanovski JA, Calis KA. 2000. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacother J Hum Pharmacol Drug Ther. 20(3):270–279.
- Khyade MS, Kasote DM, Vaikos NP. 2014. Alstonia scholaris (L.) R. Br. and Alstonia macrophylla Wall. ex G. Don: A comparative review on traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 153(1):1–18.
- Lowe ME. 1994. Pancreatic triglyceride lipase and colipase: Insights into dietary fat digestion. Gastroenterology. 107(5):1524–1536.
- Maurya A, Verma RK, Srivastava SK. 2015. Silica-based monolithic coupled column for the simultaneous determination of echitamine, N-Demethylalstogustine, and loganetin in Alstonia scholaris by RP-HPLC and optimization of extraction method. J Liq Chromatogr Relat Technol. 38(5):543–549.
- Sridhar SNC, Ginson G, Reddy POV, Tantak MP, Kumar D, Paul AT. 2017. Synthesis, evaluation and molecular modelling studies of 2-(carbazol-3-yl)-2-oxoacetamide analogues as a new class of potential pancreatic lipase inhibitors. Bioorg Med Chem. 25(2):609–620.
- World Health Organisation. 2018. Obesity and overweight. [cited 2019 Mar 23]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.